Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests

(MedPage Today) -- Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public funding. (Los Angeles Magazine)
The FDA has mandated...